Top 50 global innovative enterprises in 2014, with Illumina at the top

Source: Bioscience 2014-02-20 Beijing time on the morning of February 19, 2014, MIT Technology Review, an American science and Technology Review Magazine, rated the "top 50 global innovation enterprises in 2014", with 8 biotechnology companies on the list, and Illumina, a gene sequencing instrument company, ranked first Last year it ranked 23rd on the list and fourth on the list of biotech companies The success of Illumina, one of the top 50 global innovators in 2014, is largely related to its growing share of the genome sequencing market Currently, Illumina has 70% of the market share of genome sequencer On January 14 this year, Jay Flatley, CEO of Illumina, revealed at J.P Morgan healthcare conference that the company will release two high-end gene sequencers, hiseq x ten and nextseq 500, which makes the myth of the company's $1000 genome sequencing within reach Illumina's growth history in the field of medical testing and personalized medicine, a $1000 price tag is often seen as the cost-effectiveness of whole genome sequencing This price is reasonable for sequencing the genomes of "possible" patients By sequencing their genomes, potential medical information can be found Illumina is expected to sell its first such sequencer in March this year Other biological companies on the list are third rock ventures in 8th place, second sight in 20th place, Monsanto in 33rd place, Medtronic in 37th place, genetics England in 39th place, kaiima bio AGRITECH in 42nd place, and Arcadia Biosciences in 49th place.